A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy
Clinical trial NCT01174563 · COMPLETED
Trial details
- NCT number
- NCT01174563
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-23
- Primary completion
- 2016-12-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.